• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience.成人Evans综合征中血小板生成素受体激动剂：一项国际多中心经验
Blood. 2022 Aug 18;140(7):789-792. doi: 10.1182/blood.2022016818.
2
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.促血小板生成素受体激动剂在血液系统疾病中的应用：丹麦经验。
Platelets. 2012;23(6):423-9. doi: 10.3109/09537104.2011.634931. Epub 2011 Dec 20.
3
[Development of thrombopoietin receptor agonists].[血小板生成素受体激动剂的研发]
Rinsho Ketsueki. 2009 Oct;50(10):1434-43.
4
Real-world evidence confirms thrombopoietin receptor agonists are safe and effective for all stages of immune thrombocytopenia.
Am J Hematol. 2024 Jan;99(1):4-5. doi: 10.1002/ajh.27129. Epub 2023 Dec 8.
5
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.免疫性血小板减少症（ITP）中血小板生成素受体激动剂（TPO-RAs）的序贯治疗：我们中心的经验
Ann Hematol. 2017 Mar;96(3):507-508. doi: 10.1007/s00277-016-2896-3. Epub 2016 Dec 15.
6
Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.血小板生成素受体激动剂治疗系统性红斑狼疮相关难治性免疫性血小板减少症的疗效
J Rheumatol. 2014 Sep;41(9):1895-6. doi: 10.3899/jrheum.140080.
7
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.血小板生成素受体激动剂用于控制活动性淋巴瘤患者的免疫性血小板减少症。
Br J Haematol. 2019 Sep;186(6):e217-e219. doi: 10.1111/bjh.16114. Epub 2019 Jul 31.
8
Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.血小板生成素受体激动剂：艾曲泊帕和罗米司亭用于治疗慢性免疫性血小板减少性紫癜
Clin J Oncol Nurs. 2019 Apr 1;23(2):212-216. doi: 10.1188/19.CJON.212-216.
9
Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.病程小于6个月的免疫性血小板减少症中的血小板生成素受体激动剂
Intern Med J. 2014 May;44(5):519-21. doi: 10.1111/imj.12406.
10
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children.血小板生成素受体激动剂作为儿童新诊断的严重免疫性血小板减少症的紧急治疗方法。
Blood. 2021 Jan 7;137(1):138-141. doi: 10.1182/blood.2020006807.

引用本文的文献

1
Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care.血栓性血小板减少性紫癜与伊文氏综合征：20年常规医院护理的验证与探索
J Blood Med. 2025 Jun 7;16:279-292. doi: 10.2147/JBM.S513578. eCollection 2025.
2
A Case of Systemic Lupus Erythematosus Complicated by Secondary Evans Syndrome.一例系统性红斑狼疮合并继发性伊文氏综合征病例。
Cureus. 2025 Mar 21;17(3):e80959. doi: 10.7759/cureus.80959. eCollection 2025 Mar.
3
Combination of Evans syndrome and COVID-19: a systematic review of reported cases.伊文氏综合征与新型冠状病毒肺炎的合并症：已报告病例的系统评价
Blood Transfus. 2025 Jul-Aug;23(4):365-378. doi: 10.2450/BloodTransfus.860. Epub 2025 Feb 6.
4
Diagnostic and Therapeutic Strategies in Evans Syndrome: A Case Report and Literature Review.伊文氏综合征的诊断与治疗策略：一例报告及文献综述
Cureus. 2024 Jul 18;16(7):e64866. doi: 10.7759/cureus.64866. eCollection 2024 Jul.

本文引用的文献

1
Pediatric Evans Syndrome: A 20-year experience from a tertiary center in Brazil.小儿Evans综合征：来自巴西一家三级中心的20年经验。
Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):196-203. doi: 10.1016/j.htct.2022.01.011. Epub 2022 Feb 26.
2
Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia.硼替佐米成功治疗一名患有22q11.2缺失综合征、并发伊文氏综合征和低丙种球蛋白血症的儿童难治性免疫性血小板减少症。
Platelets. 2022 Jul 4;33(5):801-806. doi: 10.1080/09537104.2021.2002835. Epub 2022 Feb 8.
3
A full-term pregnant woman with secondary Evans syndrome caused by severe coronavirus disease 2019: a case report.一名足月孕妇因严重 2019 冠状病毒病导致埃文斯综合征（Evans syndrome）：病例报告。
J Med Case Rep. 2021 Dec 13;15(1):606. doi: 10.1186/s13256-021-03205-6.
4
Evans syndrome in adults: an observational multicenter study.成人 Evans 综合征：一项观察性多中心研究。
Blood Adv. 2021 Dec 28;5(24):5468-5478. doi: 10.1182/bloodadvances.2021005610.
5
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.血小板生成素受体激动剂在老年原发性免疫性血小板减少症患者中的真实世界应用。
Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.
6
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures.成人自身免疫性溶血性贫血：主要危险因素和诊断程序。
Expert Rev Hematol. 2020 Jun;13(6):585-597. doi: 10.1080/17474086.2020.1754791. Epub 2020 Apr 29.
7
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.成人自身免疫性溶血性贫血的诊断和治疗：首次国际共识会议的建议。
Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5.
8
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
9
Eltrombopag in long-term management of pediatric thrombocytopenia.艾曲泊帕用于儿童血小板减少症的长期管理
Clin Case Rep. 2018 Dec 10;7(1):196-201. doi: 10.1002/ccr3.1916. eCollection 2019 Jan.
10
Trans-catheter aortic valve-in-valve implantation in an elderly patient with Evans syndrome.老年埃文斯综合征患者经导管主动脉瓣中瓣植入术
J Cardiol Cases. 2016 Feb 17;13(5):146-148. doi: 10.1016/j.jccase.2016.01.003. eCollection 2016 May.

Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience.

作者信息

Fattizzo Bruno, Cecchi Nicola, Bortolotti Marta, Giordano Giulio, Patriarca Andrea, Glenthøj Andreas, Cantoni Silvia, Capecchi Marco, Chen Frederick, Mingot-Castellano Maria Eva, Napolitano Mariasanta, Frederiksen Henrik, Gonzaléz-Lopez Tomàs José, Barcellini Wilma

机构信息

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

出版信息

Blood. 2022 Aug 18;140(7):789-792. doi: 10.1182/blood.2022016818.

DOI:10.1182/blood.2022016818
PMID:35749688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9389636/
Abstract
摘要